CarsonAllaria Wealth Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-254
Closed -$13.5K 160
2025
Q2
$13.5K Sell
254
-30
-11% -$1.52K 0.01% 228
2025
Q1
$12.3K Buy
284
+38
+15% +$1.92K 0.01% 239
2024
Q4
$13.8K Hold
246
0.01% 225
2024
Q3
$16.8K Sell
246
-98
-28% -$5.53K 0.01% 220
2024
Q2
$14.5K Hold
344
0.01% 221
2024
Q1
$23.8K Buy
344
+70
+26% +$4.43K 0.01% 180
2023
Q4
$20.3K Sell
274
-74
-21% -$4.85K 0.01% 169
2023
Q3
$23.7K Sell
348
-85
-20% -$7.21K 0.02% 149
2023
Q2
$40.7K Sell
433
-18
-4% -$1.4K 0.03% 121
2023
Q1
$30.6K Hold
451
0.03% 141
2022
Q4
$22K Sell
451
-65
-13% -$2.66K 0.02% 147
2022
Q3
$17K Sell
516
-8
-2% -$330 0.02% 150
2022
Q2
$21K Buy
524
+123
+31% +$6.58K 0.02% 144
2022
Q1
$28K Sell
401
-69
-15% -$5.04K 0.03% 141
2021
Q4
$37K Buy
+470
New +$41.5K 0.03% 135

Other funds holding EXAS

CarsonAllaria Wealth Management's EXAS Position: Q3 2025 in Review

CarsonAllaria Wealth Management sold out of Exact Sciences (EXAS) in Q3 2025, closing a stake of 254 shares — an estimated $13.5K sold.

CarsonAllaria Wealth Management first reported a position in EXAS in Q4 2021 and held it in 15 quarters. The position peaked at $40.7K in Q2 2023. 568 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.

  • CarsonAllaria Wealth Management reported no remaining Exact Sciences position as of Q3 2025 after selling out during the quarter.
  • CarsonAllaria Wealth Management sold 254 Exact Sciences shares in Q3 2025, an estimated $13.5K.
  • CarsonAllaria Wealth Management first reported a position in Exact Sciences in Q4 2021 and held it in 15 quarters.
  • CarsonAllaria Wealth Management's Exact Sciences position peaked at $40.7K in Q2 2023.
  • 568 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.

Based on CarsonAllaria Wealth Management's 13F filing for Q3 2025, filed 28 Oct 2025.